2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate structure
|
Common Name | 2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate | ||
---|---|---|---|---|
CAS Number | 928754-14-7 | Molecular Weight | 212.289 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 295.4±13.0 °C at 760 mmHg | |
Molecular Formula | C11H20N2O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 132.5±19.8 °C |
Name | 2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate |
---|---|
Synonym | More Synonyms |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 295.4±13.0 °C at 760 mmHg |
Molecular Formula | C11H20N2O2 |
Molecular Weight | 212.289 |
Flash Point | 132.5±19.8 °C |
Exact Mass | 212.152481 |
PSA | 41.57000 |
LogP | 0.84 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.494 |
~91% 2-Methyl-2-prop... CAS#:928754-14-7 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; Location in patent: Page/Page column 46 ; WO 2011/050202 A1 |
~% 2-Methyl-2-prop... CAS#:928754-14-7 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
~% 2-Methyl-2-prop... CAS#:928754-14-7 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
~% 2-Methyl-2-prop... CAS#:928754-14-7 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
~% 2-Methyl-2-prop... CAS#:928754-14-7 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
~% 2-Methyl-2-prop... CAS#:928754-14-7 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50200 A1, 2011 ; WO 2011/050200 A1 |
3,8-Diaza-bicyclooctan<3.2.1> |
2-Methyl-2-propanyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate |
tert-butyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate |
3,8-diaza-bicyclo[4.2.0]octane-3-carboxylic acid tert-butyl ester |
3,8-Diazabicyclo-<-octan |
3,8-Diazabicyclo[4.2.0]octane-3-carboxylic acid, 1,1-dimethylethyl ester |
3,8-Diazabicyclo[4.2.0]octane-3-carboxylic acid 1,1-dimethylethyl ester |
3,8-DIAZA-BICYCLO[3.2.1]OCTANE |